Should all coronary patients receive hypolipidaemic drug treatment?

Autor:	K. Poulopoulos, E. Papasteriadis, G. Tsitouris, A. Velissaridou, T. Kakavas, Loukianos S. Rallidis, M. Zolindaki
Rok vydání:	2001
Předmět:	medicine.medical_specialty Drug treatment business.industry Internal medicine Internal Medicine Medicine General Medicine Cardiology and Cardiovascular Medicine business
Zdroj:	Atherosclerosis Supplements. 2:91
ISSN:	1567-5688
DOI:	10.1016/s1567-5688(01)80230-0
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::a340efe32e0d0efd59e0992a20ba8515 https://doi.org/10.1016/s1567-5688(01)80230-0 Zobrazit plný text záznamu Full Text from ScienceDirect